Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Pediatric Crohn's Disease
NCT00409682Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2007
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Abbott Laboratories. Started Apr 2007; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00409682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409682.